Related Experiment Video

Updated: Aug 15, 2026

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut
07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?

Adom Bondzi-Simpson1,2, Christopher W Seder3, Elliot Wakeam4,5

  • 1Division of General Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, ON, Canada. adom.bondzisimpson@mail.utoronto.ca.

Annals of Surgical Oncology
|August 14, 2026
PubMed
Summary

Immunotherapy has changed resectable non-small cell lung cancer (NSCLC) treatment. This study explores if lymph node dissection impacts immunotherapy effectiveness by affecting immune responses crucial for cancer treatment.

Keywords:
ChemoimmunotherapyImmune checkpoint inhibitorsImmunotherapyLymph node dissectionLymphadenectomyNodal stagingNon-small cell lung cancerSurgical oncologyThoracic surgery

More Related Videos

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.